
Gretchen Vogel
@gretchenvogel1
Science writer, contributing correspondent for Science magazine.
ID: 317838702
15-06-2011 15:16:37
1,1K Tweet
3,3K Takipçi
2,2K Takip Edilen





The principal investigators behind the RECOVERY trial (for #covid19 treatments) have now started a trial testing tecovirimat (tpoxx) for the treatment of #monkeypox. First patient was enrolled on Friday. "This is the first ever trial in patients with monkeypox", says Peter Horby @peterhorby.bsky.social.


Congrats to my former Harvard University bandmate Carolyn Bertozzi on her The Nobel Prize in chemistry! We won the Ivy League Battle of the Bands in 1986 with our rockin’ group ‘Bored Of Education’, with her on keyboards & me in spandex. news.stanford.edu/2022/10/05/car…

The SARS-CoV2 lineage soup was becoming a bit too complex to plot nicely, so here some simplified plots with lineages grouped by number of key mutations present, as suggested by Cornelius Roemer (with some help from Rodrigo Quiroga 🔬).





A funded fellowship for science writers iDiv Biodiversity Research in exciting Leipzig !!! Pls RT. Maybe interesting for @AnnieRothNews Pam Hines Fritz Habekuß Brooke Jarvis Kai Kupferschmidt Fiona Harvey Helen Thomson Sarah Laskow Dagny Lüdemann


“What has become clear to me over time is that the big challenge is not the viruses. That’s not what gives me a pit in my stomach,” he said. … Terrific piece on #h5n1 by Helen Branswell 🇨🇦: statnews.com/2023/02/08/tra…


